Market Place
Sourcing Support
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation
13 Feb 2024 //
PR NEWSWIRE
MGC Pharma`s CannEpil Accessible to UK Patients on Named Patient Request Basis
10 Apr 2023 //
PR NEWSWIRE
MGC Pharma in collaboration with HempStreet launches ArtemiC
17 Jan 2023 //
PHARMABIZ
MDPI publish peer reviewed academic paper on MGC Pharma research collaboration
04 Dec 2022 //
INVESTIGATE
MGC Pharma launches data collecting `online doctor` app with machine learning
05 Jul 2022 //
PROACTIVEINVESTORS
MGC Pharma receives patent protection for epilepsy drug
10 May 2022 //
PHARMAFILE
HempStreet announces partnership with MGC Pharma
07 May 2022 //
ET HEALTH
MGC Pharma, Sciensus Rare Partner for Distribution of Cannabinoids
05 Apr 2022 //
PRNEWSWIRE
MGC Pharmaceuticals Ltd. Approval For Global CimetrA™ Dose Finding Study
01 Nov 2021 //
INVESTEGATE
MGC Pharmaceuticals advances phase 3 clinical trial of CimetrA
12 Oct 2021 //
PROACTIVEINVESTORS
MGC Pharmaceuticals advances phase 3 clinical trial of CimetrA
11 Oct 2021 //
PROACTIVEINVESTOR
MGC Pharmaceuticals` CannEpil+ drug granted UK import permit
13 Sep 2021 //
INVESTEGATE
CDSCO approves import of MGC Pharma`s nanoparticle micellar formulation
02 Sep 2021 //
PHARMABIZ
MGC Pharma delivers year of growth for 2021 with phytocannabanoid sales
31 Aug 2021 //
PROACTIVEINVESTORS
MGC receives cash grant to help establish ArtemiC™ production in Malta
22 Dec 2020 //
PROACTIVEINVESTORS
MGC receives cash grant to help establish ArtemiC™ production in Malta
22 Dec 2020 //
PROACTIVEINVESTOR
MGC to receive full results from ArtemiC Phase II clinical trial for COVID-19
07 Dec 2020 //
PROACTIVEINVESTOR
MGC Pharma expands ArtemiC™ phII clinical trial on COVID-19 patients
28 Sep 2020 //
PROACTIVE
MGC Pharmaceuticals well-positioned in Australian market to capitalise on TGA
14 Sep 2020 //
PROACTIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.